YORK, Pa., June 17, 2011 /PRNewswire/ --Unilife Corporation (“Unilife” or the “Company”) (NASDAQ: UNIS; ASX: UNS) today hosted Kathleen Merrigan, the Deputy Secretary of the U.S. Department of Agriculture, for a White House Business Council roundtable discussion with local business leaders at its facility in York, Pennsylvania.
The White House established the White House Business Council (WHBC) under the direction of President Obama. The Winning the Future Roundtables with American Business tour now being conducted by the WHBC is enabling the Obama Administration (the “Administration”) to hear directly from U.S. business leaders about their ideas for how to continue to grow the economy, put Americans back to work, and win the future.
The WHBC meeting hosted by Unilife with local business leaders in York was amongst the first of more than 100 Council roundtables that will be held by the Administration across all 50 U.S. states by the end of the year.
Unilife’s Chief Executive Officer Mr. Alan Shortall welcomed the Agriculture Deputy Secretary, Pennsylvania State Director of the U.S. Department of Agriculture Tom Williams, other members of the White House Business Council and members of the York business community to the WHBC Roundtable Discussion.
“As an emerging leader for advanced drug delivery systems with a new and fast-growing presence in Pennsylvania, Unilife is committed to supporting U.S. programs that can accelerate opportunities for home-grown innovation, attract international investment and create jobs in the industries of tomorrow,” Mr. Shortall said.
“Unilife was honored to be invited to host the Agriculture Deputy Secretary and the White House Business Council to discuss these key important matters with members of the York business community.”
In October last year, the U.S. Department of Agriculture (USDA) agreed to guarantee $10 million of an $18 million mortgage Unilife obtained to support construction of its new $32 million global headquarters and manufacturing facility in York, Pennsylvania.
About Unilife Corporation
Unilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S. based developer, manufacturer and supplier of advanced drug delivery systems with state-of-the-art facilities in Pennsylvania. Established in 2002, Unilife works with pharmaceutical and biotechnology companies seeking innovative devices for use with their parenteral drugs and vaccines. Unilife has developed a broad, differentiated proprietary portfolio of its own injectable drug delivery products, including the Unifill® and Unitract® product lines of safety syringes with automatic, operator controlled needle retraction. Unifill represents the world’s first prefilled syringe technology integrating safety within the primary drug container. The products are ideally positioned to help pharmaceutical companies maximize the lifecycle of their injectable drugs and enhance patient care. Unifill syringes, together with other devices that are part of the Unilife technology platform, can either be supplied to pharmaceutical customers ready for use, or customized to address the specific requirements of targeted novel drugs. For more information on Unilife, please visit www.unilife.com.
This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management’s beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission.
General: UNIS-G
Investor Contacts (US): | Investor Contacts (Australia) | ||
Todd Fromer / Garth Russell | Stuart Fine | Jeff Carter | |
KCSA Strategic Communications | Carpe DM Inc | Unilife Corporation | |
P: + 1 212-682-6300 | P: + 1 908 469 1788 | P: + 61 2 8346 6500 | |
SOURCE Unilife Corporation
